Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q64339355
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241121000200.0 |
008
|
|
|
241121nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q64339355
|
024
|
|
|
‡a
0000-0002-5671-784X
‡2
orcid
|
035
|
|
|
‡a
(OCoLC)Q64339355
|
100
|
0 |
|
‡a
Roberta J Ward
‡9
fr
‡9
es
‡9
ast
|
375
|
|
|
‡a
2
‡2
iso5218
|
400
|
0 |
|
‡a
Roberta J Ward
‡c
researcher
‡9
en
|
400
|
0 |
|
‡a
Roberta J Ward
‡c
onderzoeker
‡9
nl
|
670
|
|
|
‡a
Author's A comparative study of zinc, copper, cadmium, and lead levels in fertile and infertile men
|
670
|
|
|
‡a
Author's A Mössbauer spectroscopic study of the form of iron in iron overload
|
670
|
|
|
‡a
Author's A PvuII RFLP in the human ADH2 gene.
|
670
|
|
|
‡a
Author's Acetaldehyde-induced changes in monoamine and amino acid extracellular microdialysate content of the nucleus accumbens
|
670
|
|
|
‡a
Author's Alcohol and acetaldehyde dehydrogenase gene polymorphism and alcoholism
|
670
|
|
|
‡a
Author's Alpha-tocopherol levels in brain are not altered in Parkinson's disease
|
670
|
|
|
‡a
Author's Alpha-tocopherol, lipids and lipoproteins in knee-joint synovial fluid and serum from patients with inflammatory joint disease
|
670
|
|
|
‡a
Author's An overview of iron metabolism: molecular and cellular criteria for the selection of iron chelators.
|
670
|
|
|
‡a
Author's Anti-inflammatory actions of a taurine analogue, ethane β-sultam, in phagocytic cells, in vivo and in vitro
|
670
|
|
|
‡a
Author's Assessment of trace metal intake and status in a Gujerati pregnant Asian population and their influence on the outcome of pregnancy
|
670
|
|
|
‡a
Author's Binge drinking +/- chronic nicotine administration alters extracellular glutamate and arginine levels in the nucleus accumbens of adult male and female Wistar rats.
|
670
|
|
|
‡a
Author's Biochemical and biophysical investigations of the ferrocene-iron-loaded rat. An animal model of primary haemochromatosis
|
670
|
|
|
‡a
Author's Biochemical and genetic studies of Caucasian subjects with ethanol-induced flushing reaction
|
670
|
|
|
‡a
Author's Biochemical and neurotransmitter changes implicated in alcohol-induced brain damage in chronic or 'binge drinking' alcohol abuse.
|
670
|
|
|
‡a
Author's Biochemical studies of the iron cores and polypeptide shells of haemosiderin isolated from patients with primary or secondary haemochromatosis
|
670
|
|
|
‡a
Author's Blood acetaldehyde and ethanol levels in alcoholism
|
670
|
|
|
‡a
Author's Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's disease.
|
670
|
|
|
‡a
Author's Brain iron in the ferrocene-loaded rat: its chelation and influence on dopamine metabolism
|
670
|
|
|
‡a
Author's Brain iron metabolism and its perturbation in neurological diseases.
|
670
|
|
|
‡a
Author's Changes in function of iron-loaded alveolar macrophages after in vivo administration of desferrioxamine and/or chloroquine
|
670
|
|
|
‡a
Author's Changes in plasma and urinary taurine and amino acids in runners immediately and 24h after a marathon.
|
670
|
|
|
‡a
Author's Changes in plasma taurine levels after different endurance events
|
670
|
|
|
‡a
Author's Changes in Pro-Inflammatory Markers in Detoxifying Chronic Alcohol Abusers, Divided by Lesch Typology, Reflect Cognitive Dysfunction
|
670
|
|
|
‡a
Author's Chemical and structural characterisation of iron cores of haemosiderins isolated from different sources
|
670
|
|
|
‡a
Author's Clinical and experimental skeletal muscle alcoholic myopathy.
|
670
|
|
|
‡a
Author's Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson's disease after peripheral administration
|
670
|
|
|
‡a
Author's Copper and iron homeostasis in mammalian cells and cell lines.
|
670
|
|
|
‡a
Author's Decreased release of nitric oxide
|
670
|
|
|
‡a
Author's Decreased release of nitric oxide (NO) by alveolar macrophages after in vivo loading of rats with either iron or ethanol
|
670
|
|
|
‡a
Author's Determination of antimony in biological materials by electrothermal atomic absorption spectroscopy
|
670
|
|
|
‡a
Author's Determination of gold in plasma and plasma fractions by atomic absorption spectrometry and by neutron activation analysis
|
670
|
|
|
‡a
Author's Diet and Atherosclerosis
|
670
|
|
|
‡a
Author's Does taurine play an osmolarity role during ethanol intoxication?
|
670
|
|
|
‡a
Author's Effect of chronic chloroquine administration on iron loading in the liver and reticuloendothelial system and on oxidative responses by the alveolar macrophages.
|
670
|
|
|
‡a
Author's Effect of chronic ethanol feeding on the hepatic secretion of very-low-density lipoproteins
|
670
|
|
|
‡a
Author's Effects of ethanol and glutamate agonist infusion on the outflow of sulphoacetaldehyde: microdialysis studies
|
670
|
|
|
‡a
Author's Effects of marginal iron overload on iron homeostasis and immune function in alveolar macrophages isolated from pregnant and normal rats.
|
670
|
|
|
‡a
Author's Fatty acid synthesis and triacylglycerol accumulation in rat liver after chronic ethanol consumption
|
670
|
|
|
‡a
Author's Further characterisation of forms of haemosiderin in iron-overloaded tissues
|
670
|
|
|
‡a
Author's Gas chromatographic - mass spectrometric methods for the detection and identification of anabolic steroid drugs
|
670
|
|
|
‡a
Author's Hepatic iron overload in birds: analytical and morphological studies
|
670
|
|
|
‡a
Author's Identification of the nuclear transcription factor NFkappaB in rat after in vivo ethanol administration
|
670
|
|
|
‡a
Author's Imidazole dipeptides in experimental alcohol-induced myopathy
|
670
|
|
|
‡a
Author's Influence of adolescent heavy session drinking on the systemic and brain innate immune system.
|
670
|
|
|
‡a
Author's Influence of hydroxypyridones and desferrioxamine on the mobilization of aluminium from tissues of aluminium-loaded rats
|
670
|
|
|
‡a
Author's Investigation of the aetiology of haemosiderosis in the starling (Sturnus vulgaris)
|
670
|
|
|
‡a
Author's Investigation of the therapeutic efficacy of a taurine analogue during the initial stages of ethanol detoxification: preliminary studies in chronic alcohol abusers
|
670
|
|
|
‡a
Author's Iron and the immune system
|
670
|
|
|
‡a
Author's Iron K-edge absorption spectroscopic investigations of the cores of ferritin and haemosiderins
|
670
|
|
|
‡a
Author's Iron metabolism--new perspectives in view
|
670
|
|
|
‡a
Author's Iron mobilisation and cellular protection by a new synthetic chelator O-Trensox
|
670
|
|
|
‡a
Author's Iron release from haemosiderin and ferritin by therapeutic and physiological chelators.
|
670
|
|
|
‡a
Author's Iron supplementation during pregnancy--a necessary or toxic supplement?
|
670
|
|
|
‡a
Author's Is ethanol a pro-drug? Acetaldehyde contribution to brain ethanol effects.
|
670
|
|
|
‡a
Author's Mathematical modelling of ethanol metabolism in normal subjects and chronic alcohol misusers.
|
670
|
|
|
‡a
Author's Metabolism of anabolic steroid drugs in man and the marmoset monkey (Callithrix jacchus)--I. Nilevar and Orabolin
|
670
|
|
|
‡a
Author's Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells.
|
670
|
|
|
‡a
Author's Mössbauer spectroscopic studies of deproteinised, sub-fractionated and reconstituted ferritins: the relationship between haemosiderin and ferritin
|
670
|
|
|
‡a
Author's Mössbauer spectroscopy, electron microscopy and electron diffraction studies of the iron cores in various human and animal haemosiderins
|
670
|
|
|
‡a
Author's Neurochemical pathways involved in the protective effects of nicotine and ethanol in preventing the development of Parkinson's disease: potential targets for the development of new therapeutic agents.
|
670
|
|
|
‡a
Author's Neurodegenerative diseases and therapeutic strategies using iron chelators
|
670
|
|
|
‡a
Author's New 8-hydroxyquinoline and catecholate iron chelators: influence of their partition coefficient on their biological activity.
|
670
|
|
|
‡a
Author's Nicotine increases ethanol preference but decreases locomotor activity during the initial stages of chronic ethanol withdrawal
|
670
|
|
|
‡a
Author's Nicotine-induced changes of glutamate and arginine in naive and chronically alcoholized rats: an in vivo microdialysis study.
|
670
|
|
|
‡a
Author's Production of reactive oxygen species following acute ethanol or acetaldehyde and its reduction by acamprosate in chronically alcoholized rats.
|
670
|
|
|
‡a
Author's Quantitative analysis of immunogold labelling for ferritin in liver from control and iron-overloaded rats
|
670
|
|
|
‡a
Author's Significance of blood cadmium concentrations in patients with renal disorders or essential hypertension and the normal population.
|
670
|
|
|
‡a
Author's Structural specificity of haemosiderin iron cores in iron-overload diseases
|
670
|
|
|
‡a
Author's Studies of in vivo iron mobilization by chelators in the ferrocene-loaded rat
|
670
|
|
|
‡a
Author's Taurine modulates catalase, aldehyde dehydrogenase, and ethanol elimination rates in rat brain.
|
670
|
|
|
‡a
Author's The antioxidant status of patients with either alcohol-induced liver damage or myopathy
|
670
|
|
|
‡a
Author's The effects of swabbing the skin on apparent blood ethanol concentration
|
670
|
|
|
‡a
Author's The influence of brain acetaldehyde on oxidative status, dopamine metabolism and visual discrimination task
|
670
|
|
|
‡a
Author's The influence of iron homoeostasis on macrophage function
|
670
|
|
|
‡a
Author's The role of iron in brain ageing and neurodegenerative disorders.
|
670
|
|
|
‡a
Author's The role of iron in ferritin- and haemosiderin-mediated lipid peroxidation in liposomes.
|
670
|
|
|
‡a
Author's The 'topping-up' effect: differences between low- and non-alcoholic lager on blood ethanol.
|
670
|
|
|
‡a
Author's The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis
|
670
|
|
|
‡a
Author's Ultrastructural changes in the pancreas of carbonyl iron-fed rats
|
670
|
|
|
‡a
Author's Ultrastructural observations in the carbonyl iron-fed rat, an animal model for hemochromatosis
|
670
|
|
|
‡a
Author's Women and alcohol susceptibility: could differences in alcohol metabolism predispose women to alcohol-related diseases?
|
670
|
|
|
‡a
Author's Zinc and copper in Asian pregnancies--is there evidence for a nutritional deficiency?
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/NUKAT|n 2006092543
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/ISNI|0000000116115257
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/BNF|15099107
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/viaf/27359861
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/SUDOC|221588655
|
909
|
|
|
‡a
(orcid) 000000025671784x
‡9
1
|
919
|
|
|
‡a
chemicalandstructuralcharacterisationofironcoresofhaemosiderinsisolatedfromdifferentsources
‡A
Chemical and structural characterisation of iron cores of haemosiderins isolated from different sources
‡9
1
|
919
|
|
|
‡a
clinicalandexperimentalskeletalmusclealcoholicmyopathy
‡A
Clinical and experimental skeletal muscle alcoholic myopathy.
‡9
1
|
919
|
|
|
‡a
clinicallyavailableironchelatorsinduceneuroprotectioninthe6ohdamodelofparkinsonsdiseaseafterperipheraladministration
‡A
Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson's disease after peripheral administration
‡9
1
|
919
|
|
|
‡a
copperandironhomeostasisinmammaliancellsandcelllines
‡A
Copper and iron homeostasis in mammalian cells and cell lines.
‡9
1
|
919
|
|
|
‡a
decreasedreleaseofnitricoxide
‡A
Decreased release of nitric oxide
‡9
1
|
919
|
|
|
‡a
decreasedreleaseofnitricoxidenobyalveolarmacrophagesafterinvivoloadingofratswitheitherironorethanol
‡A
Decreased release of nitric oxide (NO) by alveolar macrophages after in vivo loading of rats with either iron or ethanol
‡9
1
|
919
|
|
|
‡a
determinationofantimonyinbiologicalmaterialsbyelectrothermalatomicabsorptionspectroscopy
‡A
Determination of antimony in biological materials by electrothermal atomic absorption spectroscopy
‡9
1
|
919
|
|
|
‡a
determinationofgoldinplasmaandplasmafractionsbyatomicabsorptionspectrometryandbyneutronactivationanalysis
‡A
Determination of gold in plasma and plasma fractions by atomic absorption spectrometry and by neutron activation analysis
‡9
1
|
919
|
|
|
‡a
dietandatherosclerosis
‡A
Diet and Atherosclerosis
‡9
1
|
919
|
|
|
‡a
doestaurineplayanosmolarityroleduringethanolintoxication
‡A
Does taurine play an osmolarity role during ethanol intoxication?
‡9
1
|
919
|
|
|
‡a
effectofchronicchloroquineadministrationonironloadingintheliverandreticuloendothelialsystemandonoxidativeresponsesbythealveolarmacrophages
‡A
Effect of chronic chloroquine administration on iron loading in the liver and reticuloendothelial system and on oxidative responses by the alveolar macrophages.
‡9
1
|
919
|
|
|
‡a
effectofchronicethanolfeedingonthehepaticsecretionofverylowdensitylipoproteins
‡A
Effect of chronic ethanol feeding on the hepatic secretion of very-low-density lipoproteins
‡9
1
|
919
|
|
|
‡a
effectsofethanolandglutamateagonistinfusionontheoutflowofsulphoacetaldehydemicrodialysisstudies
‡A
Effects of ethanol and glutamate agonist infusion on the outflow of sulphoacetaldehyde: microdialysis studies
‡9
1
|
919
|
|
|
‡a
effectsofmarginalironoverloadonironhomeostasisandimmunefunctioninalveolarmacrophagesisolatedfrompregnantandnormalrats
‡A
Effects of marginal iron overload on iron homeostasis and immune function in alveolar macrophages isolated from pregnant and normal rats.
‡9
1
|
919
|
|
|
‡a
fattyacidsynthesisandtriacylglycerolaccumulationinratliverafterchronicethanolconsumption
‡A
Fatty acid synthesis and triacylglycerol accumulation in rat liver after chronic ethanol consumption
‡9
1
|
919
|
|
|
‡a
furthercharacterisationofformsofhaemosiderininironoverloadedtissues
‡A
Further characterisation of forms of haemosiderin in iron-overloaded tissues
‡9
1
|
919
|
|
|
‡a
gaschromatographicmassspectrometricmethodsforthedetectionandidentificationofanabolicsteroiddrugs
‡A
Gas chromatographic - mass spectrometric methods for the detection and identification of anabolic steroid drugs
‡9
1
|
919
|
|
|
‡a
hepaticironoverloadinbirdsanalyticalandmorphologicalstudies
‡A
Hepatic iron overload in birds: analytical and morphological studies
‡9
1
|
919
|
|
|
‡a
identificationofthenucleartranscriptionfactornfkappabinratafterinvivoethanoladministration
‡A
Identification of the nuclear transcription factor NFkappaB in rat after in vivo ethanol administration
‡9
1
|
919
|
|
|
‡a
imidazoledipeptidesinexperimentalalcoholinducedmyopathy
‡A
Imidazole dipeptides in experimental alcohol-induced myopathy
‡9
1
|
919
|
|
|
‡a
influenceofadolescentheavysessiondrinkingonthesystemicandbraininnateimmunesystem
‡A
Influence of adolescent heavy session drinking on the systemic and brain innate immune system.
‡9
1
|
919
|
|
|
‡a
influenceofhydroxypyridonesanddesferrioxamineonthemobilizationofaluminiumfromtissuesofaluminiumloadedrats
‡A
Influence of hydroxypyridones and desferrioxamine on the mobilization of aluminium from tissues of aluminium-loaded rats
‡9
1
|
919
|
|
|
‡a
investigationoftheaetiologyofhaemosiderosisinthestarlingsturnusvulgaris
‡A
Investigation of the aetiology of haemosiderosis in the starling (Sturnus vulgaris)
‡9
1
|
919
|
|
|
‡a
investigationofthetherapeuticefficacyofataurineanalogueduringtheinitialstagesofethanoldetoxificationpreliminarystudiesinchronicalcoholabusers
‡A
Investigation of the therapeutic efficacy of a taurine analogue during the initial stages of ethanol detoxification: preliminary studies in chronic alcohol abusers
‡9
1
|
919
|
|
|
‡a
ironandtheimmunesystem
‡A
Iron and the immune system
‡9
1
|
919
|
|
|
‡a
ironkedgeabsorptionspectroscopicinvestigationsofthecoresofferritinandhaemosiderins
‡A
Iron K-edge absorption spectroscopic investigations of the cores of ferritin and haemosiderins
‡9
1
|
919
|
|
|
‡a
ironmetabolismnewperspectivesinview
‡A
Iron metabolism--new perspectives in view
‡9
1
|
919
|
|
|
‡a
ironmobilisationandcellularprotectionbyanewsyntheticchelatorotrensox
‡A
Iron mobilisation and cellular protection by a new synthetic chelator O-Trensox
‡9
1
|
919
|
|
|
‡a
ironreleasefromhaemosiderinandferritinbytherapeuticandphysiologicalchelators
‡A
Iron release from haemosiderin and ferritin by therapeutic and physiological chelators.
‡9
1
|
919
|
|
|
‡a
ironsupplementationduringpregnancyanecessaryortoxicsupplement
‡A
Iron supplementation during pregnancy--a necessary or toxic supplement?
‡9
1
|
919
|
|
|
‡a
isethanolaprodrugacetaldehydecontributiontobrainethanoleffects
‡A
Is ethanol a pro-drug? Acetaldehyde contribution to brain ethanol effects.
‡9
1
|
919
|
|
|
‡a
mathematicalmodellingofethanolmetabolisminnormalsubjectsandchronicalcoholmisusers
‡A
Mathematical modelling of ethanol metabolism in normal subjects and chronic alcohol misusers.
‡9
1
|
919
|
|
|
‡a
metabolismofanabolicsteroiddrugsinmanandthemarmosetmonkeycallithrixjacchus1nilevarandorabolin
‡A
Metabolism of anabolic steroid drugs in man and the marmoset monkey (Callithrix jacchus)--I. Nilevar and Orabolin
‡9
1
|
919
|
|
|
‡a
molecularandcellularmechanismsofironhomeostasisandtoxicityinmammaliancells
‡A
Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells.
‡9
1
|
919
|
|
|
‡a
mossbauerspectroscopicstudiesofdeproteinisedsubfractionatedandreconstitutedferritinstherelationshipbetweenhaemosiderinandferritin
‡A
Mössbauer spectroscopic studies of deproteinised, sub-fractionated and reconstituted ferritins: the relationship between haemosiderin and ferritin
‡9
1
|
919
|
|
|
‡a
mossbauerspectroscopyelectronmicroscopyandelectrondiffractionstudiesoftheironcoresinvarioushumanandanimalhaemosiderins
‡A
Mössbauer spectroscopy, electron microscopy and electron diffraction studies of the iron cores in various human and animal haemosiderins
‡9
1
|
919
|
|
|
‡a
neurochemicalpathwaysinvolvedintheprotectiveeffectsofnicotineandethanolinpreventingthedevelopmentofparkinsonsdiseasepotentialtargetsforthedevelopmentofnewtherapeuticagents
‡A
Neurochemical pathways involved in the protective effects of nicotine and ethanol in preventing the development of Parkinson's disease: potential targets for the development of new therapeutic agents.
‡9
1
|
919
|
|
|
‡a
neurodegenerativediseasesandtherapeuticstrategiesusingironchelators
‡A
Neurodegenerative diseases and therapeutic strategies using iron chelators
‡9
1
|
919
|
|
|
‡a
new8hydroxyquinolineandcatecholateironchelatorsinfluenceoftheirpartitioncoefficientontheirbiologicalactivity
‡A
New 8-hydroxyquinoline and catecholate iron chelators: influence of their partition coefficient on their biological activity.
‡9
1
|
919
|
|
|
‡a
nicotineincreasesethanolpreferencebutdecreaseslocomotoractivityduringtheinitialstagesofchronicethanolwithdrawal
‡A
Nicotine increases ethanol preference but decreases locomotor activity during the initial stages of chronic ethanol withdrawal
‡9
1
|
919
|
|
|
‡a
nicotineinducedchangesofglutamateandarginineinnaiveandchronicallyalcoholizedratsaninvivomicrodialysisstudy
‡A
Nicotine-induced changes of glutamate and arginine in naive and chronically alcoholized rats: an in vivo microdialysis study.
‡9
1
|
919
|
|
|
‡a
productionofreactiveoxygenspeciesfollowingacuteethanoloracetaldehydeanditsreductionbyacamprosateinchronicallyalcoholizedrats
‡A
Production of reactive oxygen species following acute ethanol or acetaldehyde and its reduction by acamprosate in chronically alcoholized rats.
‡9
1
|
919
|
|
|
‡a
quantitativeanalysisofimmunogoldlabellingforferritininliverfromcontrolandironoverloadedrats
‡A
Quantitative analysis of immunogold labelling for ferritin in liver from control and iron-overloaded rats
‡9
1
|
919
|
|
|
‡a
significanceofbloodcadmiumconcentrationsinpatientswithrenaldisordersoressentialhypertensionandthenormalpopulation
‡A
Significance of blood cadmium concentrations in patients with renal disorders or essential hypertension and the normal population.
‡9
1
|
919
|
|
|
‡a
structuralspecificityofhaemosiderinironcoresinironoverloaddiseases
‡A
Structural specificity of haemosiderin iron cores in iron-overload diseases
‡9
1
|
919
|
|
|
‡a
studiesofinvivoironmobilizationbychelatorsintheferroceneloadedrat
‡A
Studies of in vivo iron mobilization by chelators in the ferrocene-loaded rat
‡9
1
|
919
|
|
|
‡a
taurinemodulatescatalasealdehydedehydrogenaseandethanoleliminationratesinratbrain
‡A
Taurine modulates catalase, aldehyde dehydrogenase, and ethanol elimination rates in rat brain.
‡9
1
|
919
|
|
|
‡a
antioxidantstatusofpatientswitheitheralcoholinducedliverdamageormyopathy
‡A
The antioxidant status of patients with either alcohol-induced liver damage or myopathy
‡9
1
|
919
|
|
|
‡a
effectsofswabbingtheskinonapparentbloodethanolconcentration
‡A
The effects of swabbing the skin on apparent blood ethanol concentration
‡9
1
|
919
|
|
|
‡a
influenceofbrainacetaldehydeonoxidativestatusdopaminemetabolismandvisualdiscriminationtask
‡A
The influence of brain acetaldehyde on oxidative status, dopamine metabolism and visual discrimination task
‡9
1
|
919
|
|
|
‡a
influenceofironhomoeostasisonmacrophagefunction
‡A
The influence of iron homoeostasis on macrophage function
‡9
1
|
919
|
|
|
‡a
roleofironinbrainageingandneurodegenerativedisorders
‡A
The role of iron in brain ageing and neurodegenerative disorders.
‡9
1
|
919
|
|
|
‡a
roleofironinferritinandhaemosiderinmediatedlipidperoxidationinliposomes
‡A
The role of iron in ferritin- and haemosiderin-mediated lipid peroxidation in liposomes.
‡9
1
|
919
|
|
|
‡a
toppingupeffectdifferencesbetweenlowandnonalcoholiclageronbloodethanol
‡A
The 'topping-up' effect: differences between low- and non-alcoholic lager on blood ethanol.
‡9
1
|
919
|
|
|
‡a
useofpentostamliposomesinthechemotherapyofexperimentalleishmaniasis
‡A
The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis
‡9
1
|
919
|
|
|
‡a
ultrastructuralchangesinthepancreasofcarbonylironfedrats
‡A
Ultrastructural changes in the pancreas of carbonyl iron-fed rats
‡9
1
|
919
|
|
|
‡a
ultrastructuralobservationsinthecarbonylironfedratananimalmodelforhemochromatosis
‡A
Ultrastructural observations in the carbonyl iron-fed rat, an animal model for hemochromatosis
‡9
1
|
919
|
|
|
‡a
womenandalcoholsusceptibilitycoulddifferencesinalcoholmetabolismpredisposewomentoalcoholrelateddiseases
‡A
Women and alcohol susceptibility: could differences in alcohol metabolism predispose women to alcohol-related diseases?
‡9
1
|
919
|
|
|
‡a
zincandcopperinasianpregnanciesisthereevidenceforanutritionaldeficiency
‡A
Zinc and copper in Asian pregnancies--is there evidence for a nutritional deficiency?
‡9
1
|
919
|
|
|
‡a
comparativestudyofzinccoppercadmiumandleadlevelsinfertileandinfertilemen
‡A
A comparative study of zinc, copper, cadmium, and lead levels in fertile and infertile men
‡9
1
|
919
|
|
|
‡a
mossbauerspectroscopicstudyoftheformofironinironoverload
‡A
A Mössbauer spectroscopic study of the form of iron in iron overload
‡9
1
|
919
|
|
|
‡a
pvuiirflpinthehumanadh2gene
‡A
A PvuII RFLP in the human ADH2 gene.
‡9
1
|
919
|
|
|
‡a
acetaldehydeinducedchangesinmonoamineandaminoacidextracellularmicrodialysatecontentofthenucleusaccumbens
‡A
Acetaldehyde-induced changes in monoamine and amino acid extracellular microdialysate content of the nucleus accumbens
‡9
1
|
919
|
|
|
‡a
alcoholandacetaldehydedehydrogenasegenepolymorphismandalcoholism
‡A
Alcohol and acetaldehyde dehydrogenase gene polymorphism and alcoholism
‡9
1
|
919
|
|
|
‡a
alphatocopherollevelsinbrainarenotalteredinparkinsonsdisease
‡A
Alpha-tocopherol levels in brain are not altered in Parkinson's disease
‡9
1
|
919
|
|
|
‡a
alphatocopherollipidsandlipoproteinsinkneejointsynovialfluidandserumfrompatientswithinflammatoryjointdisease
‡A
Alpha-tocopherol, lipids and lipoproteins in knee-joint synovial fluid and serum from patients with inflammatory joint disease
‡9
1
|
919
|
|
|
‡a
overviewofironmetabolismmolecularandcellularcriteriafortheselectionofironchelators
‡A
An overview of iron metabolism: molecular and cellular criteria for the selection of iron chelators.
‡9
1
|
919
|
|
|
‡a
antiinflammatoryactionsofataurineanalogueethaneβsultaminphagocyticcellsinvivoandinvitro
‡A
Anti-inflammatory actions of a taurine analogue, ethane β-sultam, in phagocytic cells, in vivo and in vitro
‡9
1
|
919
|
|
|
‡a
assessmentoftracemetalintakeandstatusinagujeratipregnantasianpopulationandtheirinfluenceontheoutcomeofpregnancy
‡A
Assessment of trace metal intake and status in a Gujerati pregnant Asian population and their influence on the outcome of pregnancy
‡9
1
|
919
|
|
|
‡a
bingedrinking+chronicnicotineadministrationaltersextracellularglutamateandargininelevelsinthenucleusaccumbensofadultmaleandfemalewistarrats
‡A
Binge drinking +/- chronic nicotine administration alters extracellular glutamate and arginine levels in the nucleus accumbens of adult male and female Wistar rats.
‡9
1
|
919
|
|
|
‡a
biochemicalandbiophysicalinvestigationsoftheferroceneironloadedratananimalmodelofprimaryhaemochromatosis
‡A
Biochemical and biophysical investigations of the ferrocene-iron-loaded rat. An animal model of primary haemochromatosis
‡9
1
|
919
|
|
|
‡a
biochemicalandgeneticstudiesofcaucasiansubjectswithethanolinducedflushingreaction
‡A
Biochemical and genetic studies of Caucasian subjects with ethanol-induced flushing reaction
‡9
1
|
919
|
|
|
‡a
biochemicalandneurotransmitterchangesimplicatedinalcoholinducedbraindamageinchronicorbingedrinkingalcoholabuse
‡A
Biochemical and neurotransmitter changes implicated in alcohol-induced brain damage in chronic or 'binge drinking' alcohol abuse.
‡9
1
|
919
|
|
|
‡a
biochemicalstudiesoftheironcoresandpolypeptideshellsofhaemosiderinisolatedfrompatientswithprimaryorsecondaryhaemochromatosis
‡A
Biochemical studies of the iron cores and polypeptide shells of haemosiderin isolated from patients with primary or secondary haemochromatosis
‡9
1
|
919
|
|
|
‡a
bloodacetaldehydeandethanollevelsinalcoholism
‡A
Blood acetaldehyde and ethanol levels in alcoholism
‡9
1
|
919
|
|
|
‡a
brainironchelationbydeferiproneinaphase2randomiseddoubleblindedplacebocontrolledclinicaltrialinparkinsonsdisease
‡A
Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's disease.
‡9
1
|
919
|
|
|
‡a
brainironintheferroceneloadedratitschelationandinfluenceondopaminemetabolism
‡A
Brain iron in the ferrocene-loaded rat: its chelation and influence on dopamine metabolism
‡9
1
|
919
|
|
|
‡a
brainironmetabolismanditsperturbationinneurologicaldiseases
‡A
Brain iron metabolism and its perturbation in neurological diseases.
‡9
1
|
919
|
|
|
‡a
changesinfunctionofironloadedalveolarmacrophagesafterinvivoadministrationofdesferrioxamineandorchloroquine
‡A
Changes in function of iron-loaded alveolar macrophages after in vivo administration of desferrioxamine and/or chloroquine
‡9
1
|
919
|
|
|
‡a
changesinplasmaandurinarytaurineandaminoacidsinrunnersimmediatelyand24hafteramarathon
‡A
Changes in plasma and urinary taurine and amino acids in runners immediately and 24h after a marathon.
‡9
1
|
919
|
|
|
‡a
changesinplasmataurinelevelsafterdifferentenduranceevents
‡A
Changes in plasma taurine levels after different endurance events
‡9
1
|
919
|
|
|
‡a
changesinproinflammatorymarkersindetoxifyingchronicalcoholabusersdividedbyleschtypologyreflectcognitivedysfunction
‡A
Changes in Pro-Inflammatory Markers in Detoxifying Chronic Alcohol Abusers, Divided by Lesch Typology, Reflect Cognitive Dysfunction
‡9
1
|
946
|
|
|
‡a
a
‡9
1
|
996
|
|
|
‡2
DNB|118877615
|
996
|
|
|
‡2
DNB|1060039664
|
996
|
|
|
‡2
RERO|A012335010
|
996
|
|
|
‡2
BNF|15968605
|
996
|
|
|
‡2
NTA|323969062
|
996
|
|
|
‡2
J9U|987007328379005171
|
996
|
|
|
‡2
BLBNB|000468178
|
996
|
|
|
‡2
ISNI|0000000108374275
|
996
|
|
|
‡2
ISNI|0000000107992899
|
996
|
|
|
‡2
LC|no2020044997
|
996
|
|
|
‡2
BIBSYS|90814947
|
996
|
|
|
‡2
NUKAT|n 2019146796
|
996
|
|
|
‡2
LC|n 95800260
|
996
|
|
|
‡2
J9U|987007290789505171
|
996
|
|
|
‡2
LC|n 88072847
|
996
|
|
|
‡2
NKC|kup19980000109918
|
996
|
|
|
‡2
LC|n 2006040153
|
996
|
|
|
‡2
LC|no2021119781
|
996
|
|
|
‡2
J9U|987007429984805171
|
996
|
|
|
‡2
BIBSYS|13002302
|
996
|
|
|
‡2
NII|DA03975812
|
996
|
|
|
‡2
J9U|987007432520705171
|
996
|
|
|
‡2
LNB|LNC10-000209670
|
996
|
|
|
‡2
NTA|073377945
|
996
|
|
|
‡2
J9U|987007436089605171
|
996
|
|
|
‡2
NTA|130210463
|
996
|
|
|
‡2
ISNI|0000000402380393
|
996
|
|
|
‡2
DNB|142692700
|
996
|
|
|
‡2
ISNI|0000000053043646
|
996
|
|
|
‡2
BIBSYS|54646
|
996
|
|
|
‡2
J9U|987007323028805171
|
996
|
|
|
‡2
LC|n 80016938
|
996
|
|
|
‡2
LC|nb2013001887
|
996
|
|
|
‡2
BIBSYS|1602157054259
|
996
|
|
|
‡2
NUKAT|nx2023746359
|
996
|
|
|
‡2
LNB|LNC10-000341242
|
996
|
|
|
‡2
J9U|987007278448905171
|
996
|
|
|
‡2
J9U|987007339508405171
|
996
|
|
|
‡2
J9U|987007331183605171
|
996
|
|
|
‡2
NII|DA19869428
|
996
|
|
|
‡2
ISNI|0000000084800208
|
996
|
|
|
‡2
RERO|A003958189
|
996
|
|
|
‡2
RERO|A003958188
|
996
|
|
|
‡2
N6I|vtls000089215
|
996
|
|
|
‡2
NTA|142828661
|
996
|
|
|
‡2
BIBSYS|90814297
|
996
|
|
|
‡2
CAOONL|ncf11300023
|
996
|
|
|
‡2
NYNYRILM|176679
|
996
|
|
|
‡2
RERO|A006137095
|
996
|
|
|
‡2
BNF|12279424
|
996
|
|
|
‡2
J9U|987007388973705171
|
996
|
|
|
‡2
N6I|vtls000849158
|
996
|
|
|
‡2
RERO|A012330543
|
996
|
|
|
‡2
BIBSYS|90547442
|
996
|
|
|
‡2
JPG|500245694
|
996
|
|
|
‡2
BIBSYS|2035160
|
996
|
|
|
‡2
LC|n 85290196
|
996
|
|
|
‡2
BIBSYS|90058979
|
996
|
|
|
‡2
ISNI|0000000455881490
|
996
|
|
|
‡2
PTBNP|1554748
|
996
|
|
|
‡2
LC|no2017010015
|
996
|
|
|
‡2
ISNI|0000000083536855
|
996
|
|
|
‡2
J9U|987011288398505171
|
996
|
|
|
‡2
BLBNB|000385200
|
996
|
|
|
‡2
LC|nb2021015021
|
996
|
|
|
‡2
BIBSYS|90627660
|
996
|
|
|
‡2
DNB|173084362
|
996
|
|
|
‡2
LC|no2008018920
|
996
|
|
|
‡2
SUDOC|262620596
|
996
|
|
|
‡2
LC|nb2021014937
|
996
|
|
|
‡2
SUDOC|106907441
|
996
|
|
|
‡2
LC|n 2015064059
|
996
|
|
|
‡2
NII|DA08090663
|
996
|
|
|
‡2
SUDOC|221588655
|
996
|
|
|
‡2
SUDOC|12303373X
|
996
|
|
|
‡2
SUDOC|098502506
|
996
|
|
|
‡2
J9U|987007325076105171
|
996
|
|
|
‡2
ISNI|0000000078521309
|
996
|
|
|
‡2
NUKAT|n 2015146600
|
996
|
|
|
‡2
NUKAT|n 00011618
|
996
|
|
|
‡2
SUDOC|152687440
|
996
|
|
|
‡2
SUDOC|200264796
|
996
|
|
|
‡2
LC|n 81142523
|
996
|
|
|
‡2
SUDOC|085943975
|
996
|
|
|
‡2
BNF|12315409
|
996
|
|
|
‡2
BNF|15099107
|
996
|
|
|
‡2
BIBSYS|90605240
|
996
|
|
|
‡2
DNB|140459049
|
996
|
|
|
‡2
ISNI|0000000038552098
|
996
|
|
|
‡2
ISNI|0000000037095163
|
996
|
|
|
‡2
LC|nb2014015466
|
996
|
|
|
‡2
LC|n 82071911
|
996
|
|
|
‡2
LC|n 86810700
|
996
|
|
|
‡2
BNF|12276957
|
996
|
|
|
‡2
NTA|119007533
|
996
|
|
|
‡2
SUDOC|031613187
|
996
|
|
|
‡2
LC|n 2018024619
|
996
|
|
|
‡2
LNB|LNC10-000124868
|
996
|
|
|
‡2
LC|nb 99119164
|
996
|
|
|
‡2
ISNI|0000000116115257
|
996
|
|
|
‡2
ISNI|0000000496997051
|
996
|
|
|
‡2
LC|n 2002034529
|
996
|
|
|
‡2
J9U|987007277325205171
|
996
|
|
|
‡2
BNF|15553730
|
996
|
|
|
‡2
J9U|987007344565405171
|
996
|
|
|
‡2
LC|n 87926960
|
996
|
|
|
‡2
ISNI|0000000396742350
|
996
|
|
|
‡2
NUKAT|n 2009110502
|
996
|
|
|
‡2
NII|DA14789638
|
996
|
|
|
‡2
BNF|13598415
|
996
|
|
|
‡2
LC|n 87858951
|
996
|
|
|
‡2
PLWABN|9810641607105606
|
996
|
|
|
‡2
LC|no 00010858
|
996
|
|
|
‡2
ISNI|0000000024659476
|
996
|
|
|
‡2
NUKAT|n 2010056552
|
996
|
|
|
‡2
N6I|vtls000099600
|
996
|
|
|
‡2
SUDOC|074230549
|
996
|
|
|
‡2
ISNI|0000000078170617
|
996
|
|
|
‡2
LC|nb2018024821
|
996
|
|
|
‡2
NTA|068657838
|
996
|
|
|
‡2
NTA|073810924
|
996
|
|
|
‡2
LC|n 79116300
|
996
|
|
|
‡2
ISNI|0000000054296258
|
996
|
|
|
‡2
LC|nr 94039573
|
996
|
|
|
‡2
LC|n 2024015057
|
996
|
|
|
‡2
NTA|072876727
|
996
|
|
|
‡2
LC|n 88020534
|
996
|
|
|
‡2
LC|no 99090522
|
996
|
|
|
‡2
CAOONL|ncf10450526
|
996
|
|
|
‡2
BNF|15102507
|
996
|
|
|
‡2
NKC|mzk2008479766
|
996
|
|
|
‡2
LC|nr2004034121
|
996
|
|
|
‡2
NII|DA02318554
|
996
|
|
|
‡2
LC|n 2002103402
|
996
|
|
|
‡2
CAOONL|ncf10276574
|
996
|
|
|
‡2
RERO|A011261577
|
996
|
|
|
‡2
LC|no2001014959
|
996
|
|
|
‡2
LC|no2023093776
|
996
|
|
|
‡2
ISNI|0000000114491865
|
996
|
|
|
‡2
ISNI|000000003874126X
|
996
|
|
|
‡2
LC|no2002022062
|
996
|
|
|
‡2
LC|no 90009569
|
996
|
|
|
‡2
LC|no2010058592
|
996
|
|
|
‡2
CAOONL|ncf10149795
|
996
|
|
|
‡2
CAOONL|ncf11056494
|
996
|
|
|
‡2
RERO|A005541001
|
996
|
|
|
‡2
J9U|987007463439305171
|
996
|
|
|
‡2
CAOONL|ncf11433355
|
996
|
|
|
‡2
LC|no 97058372
|
996
|
|
|
‡2
DNB|120896346
|
996
|
|
|
‡2
LC|no2008156193
|
996
|
|
|
‡2
ISNI|0000000082753022
|
996
|
|
|
‡2
LC|n 50021722
|
996
|
|
|
‡2
PLWABN|9810644891805606
|
996
|
|
|
‡2
ISNI|000000007904417X
|
996
|
|
|
‡2
ISNI|0000000501260557
|
996
|
|
|
‡2
ISNI|0000000083833243
|
996
|
|
|
‡2
DNB|1079916318
|
996
|
|
|
‡2
LC|no2004101312
|
996
|
|
|
‡2
NII|DA10130192
|
996
|
|
|
‡2
ISNI|0000000388967760
|
996
|
|
|
‡2
J9U|987007333417505171
|
996
|
|
|
‡2
NUKAT|n 2012168679
|
996
|
|
|
‡2
LC|n 2015012249
|
996
|
|
|
‡2
SUDOC|280769660
|
996
|
|
|
‡2
LC|no2021043238
|
996
|
|
|
‡2
ISNI|000000011574684X
|
996
|
|
|
‡2
ISNI|0000000140285424
|
996
|
|
|
‡2
ISNI|0000000026311668
|
996
|
|
|
‡2
DNB|1106414020
|
996
|
|
|
‡2
ISNI|0000000053883354
|
996
|
|
|
‡2
DNB|173084354
|
996
|
|
|
‡2
LC|no2008017089
|
996
|
|
|
‡2
J9U|987007435320605171
|
996
|
|
|
‡2
NTA|131047868
|
996
|
|
|
‡2
NII|DA05923649
|
996
|
|
|
‡2
LIH|LNB:_i_5N;=BS
|
996
|
|
|
‡2
NTA|126957037
|
996
|
|
|
‡2
ISNI|0000000053964824
|
996
|
|
|
‡2
LC|nr 95033302
|
996
|
|
|
‡2
LC|no2015014193
|
996
|
|
|
‡2
BNCHL|10000000000000000178078
|
996
|
|
|
‡2
J9U|987007425867105171
|
996
|
|
|
‡2
RERO|A003958207
|
996
|
|
|
‡2
CAOONL|ncf11879907
|
996
|
|
|
‡2
ISNI|0000000074276561
|
996
|
|
|
‡2
N6I|vtls000037159
|
996
|
|
|
‡2
DNB|1265506477
|
996
|
|
|
‡2
NLA|000035591158
|
996
|
|
|
‡2
LC|no2020045174
|
996
|
|
|
‡2
LC|n 84076860
|
996
|
|
|
‡2
NKC|utb2015857406
|
996
|
|
|
‡2
ISNI|0000000030645441
|
996
|
|
|
‡2
J9U|987007265261305171
|
996
|
|
|
‡2
NUKAT|n 99008098
|
996
|
|
|
‡2
LC|n 86810714
|
996
|
|
|
‡2
ISNI|0000000082193088
|
996
|
|
|
‡2
LC|n 80150272
|
996
|
|
|
‡2
CAOONL|ncf11560713
|
996
|
|
|
‡2
NUKAT|n 2008073636
|
996
|
|
|
‡2
NII|DA05373752
|
996
|
|
|
‡2
J9U|987007275841105171
|
996
|
|
|
‡2
SUDOC|271194197
|
996
|
|
|
‡2
ISNI|0000000114682194
|
996
|
|
|
‡2
NII|DA00863958
|
996
|
|
|
‡2
ISNI|0000000398552163
|
996
|
|
|
‡2
NYNYRILM|18006
|
996
|
|
|
‡2
PLWABN|9810530677805606
|
996
|
|
|
‡2
NUKAT|n 2014094866
|
996
|
|
|
‡2
PLWABN|9810677449105606
|
996
|
|
|
‡2
SUDOC|152809708
|
996
|
|
|
‡2
LC|n 2014004716
|
996
|
|
|
‡2
ISNI|0000000401653265
|
996
|
|
|
‡2
CAOONL|ncf11542956
|
996
|
|
|
‡2
RERO|A010166515
|
996
|
|
|
‡2
ISNI|000000004663734X
|
996
|
|
|
‡2
J9U|987007605192005171
|
996
|
|
|
‡2
ISNI|0000000384926849
|
996
|
|
|
‡2
NII|DA13249690
|
996
|
|
|
‡2
J9U|987007319802805171
|
996
|
|
|
‡2
ISNI|000000002843416X
|
996
|
|
|
‡2
SUDOC|069225125
|
996
|
|
|
‡2
ISNI|0000000074145342
|
996
|
|
|
‡2
ISNI|0000000031361731
|
996
|
|
|
‡2
NUKAT|n 2002040384
|
996
|
|
|
‡2
NKC|nlk20030130392
|
996
|
|
|
‡2
NKC|xx0246282
|
996
|
|
|
‡2
BIBSYS|353
|
996
|
|
|
‡2
J9U|987007326562105171
|
996
|
|
|
‡2
LC|nb2013003569
|
996
|
|
|
‡2
LC|no2005075787
|
996
|
|
|
‡2
ISNI|0000000118332685
|
996
|
|
|
‡2
CAOONL|ncf11453090
|
996
|
|
|
‡2
ISNI|0000000375726431
|
996
|
|
|
‡2
DNB|1203078595
|
996
|
|
|
‡2
BIBSYS|90519147
|
996
|
|
|
‡2
LC|nr 00019893
|
996
|
|
|
‡2
SUDOC|264829050
|
996
|
|
|
‡2
ISNI|0000000368477588
|
996
|
|
|
‡2
NTA|334219280
|
996
|
|
|
‡2
CAOONL|ncf11262225
|
996
|
|
|
‡2
LC|n 89623416
|
996
|
|
|
‡2
SUDOC|150363877
|
996
|
|
|
‡2
DNB|1309717028
|
996
|
|
|
‡2
LIH|LNB:V-341986;=BR
|
996
|
|
|
‡2
BNF|12415166
|
996
|
|
|
‡2
SUDOC|131296574
|
996
|
|
|
‡2
LC|n 88046330
|
996
|
|
|
‡2
LC|no2003049807
|
996
|
|
|
‡2
SUDOC|15970118X
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
998
|
|
|
‡a
Ward, Roberta J.
‡2
ISNI|0000000116115257
‡3
suggested
|
998
|
|
|
‡a
Ward
‡b
Roberta J.
‡2
BNF|15099107
‡3
suggested
|
998
|
|
|
‡a
Ward, Roberta J.
‡2
J9U|987007328379005171
‡3
suggested
|
998
|
|
|
‡a
Ward, Roberta J.
‡2
NUKAT|n 2006092543
‡3
suggested
‡3
viafid
|
998
|
|
|
‡a
Ward, Roberta J.,
‡2
SUDOC|221588655
‡3
suggested
|
998
|
|
|
‡a
Ward, Roberta J.
‡2
BIBSYS|8008582
‡3
viafid
|